{"disease":{"id":"delayed-ischemic-neurological-deficit","name":"delayed ischemic neurological deficit"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04998370","title":"Cerebrospinal Fluid Hemoglobin to Monitor for Aneurysmal Subarachnoid Hemorrhage Related Secondary Brain Injury","phase":"","overall_status":"COMPLETED","enrollment_count":366,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT01787123","title":"Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Kwong Wah Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}